Abbott Laboratories

BVL:ABT

Stati Uniti / Sanità / Attrezzature e rifornimenti sanitari

Panoramica

Notizie

Cronol. dati finanziari 10 anni

Prezzo azione

128,20 USD


Key Metrics	Latest
Total Revenue	41,95 B
Adjusted EBITDA	10,714 B
EBITDA Margin	25,5%
Net Profit Margin	32,2%
Total Assets	81,414 B
Total Debt	15,275 B

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	41,950
% Growth		2.2%	31.3%	11.6%	4.3%	8.5%	24.5%	1.3%	-8.1%	4.6%

Adjusted EBITDA	4,389	4,569	5,957	7,116	7,771	8,789	12,742	12,380	10,463	10,714	10,714
% Margin	21.5%	21.9%	21.7%	23.3%	24.4%	25.4%	29.6%	28.4%	26.1%	25.5%	25.5%

Adjusted EBIT	2,962	3,218	2,938	3,838	4,757	5,462	9,204	9,113	7,220	7,496	7,496
% Margin	14.5%	15.4%	10.7%	12.6%	14.9%	15.8%	21.4%	20.9%	18.0%	17.9%	17.9%

Adjusted Net Income	4,282	2,124	481	2,512	3,734	4,506	7,448	7,188	5,901	13,497	13,497
% Margin	21.0%	10.2%	1.8%	8.2%	11.7%	13.0%	17.3%	16.5%	14.7%	32.2%	32.2%

Adjusted Basic EPS	2.86	1.44	0.28	1.43	2.11	2.54	4.20	4.10	3.39	7.76	7.76

Calcoli supportati

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	41,950
% Growth	NA	2.2%	31.3%	11.6%	4.3%	8.5%	24.5%	1.3%	-8.1%	4.6%

Cost of Revenue	(8,729)	(9,085)	(11,490)	(12,696)	(13,231)	(15,003)	(18,080)	(19,083)	(17,919)	(18,644)	(18,644)
Gross Profit	11,676	11,768	15,900	17,882	18,673	19,605	24,995	24,570	22,190	23,306	23,306
% Revenue	57.2%	56.4%	58.1%	58.5%	58.5%	56.6%	58.0%	56.3%	55.3%	55.6%	55.6%

Research and Development	(1,405)	(1,447)	(2,260)	(2,300)	(2,440)	(2,420)	(2,742)	(2,888)	(2,741)	(2,844)	(2,844)
Selling and Marketing	0	0	0	0	0	0	0	0	0	0	0
General and Admin	(6,742)	(6,558)	(8,804)	(9,568)	(9,540)	(9,591)	(11,006)	(10,703)	(10,385)	(11,109)	(11,109)
Other Inc / (Exp)	(288)	(2,018)	(1,825)	(2,420)	(2,040)	(2,126)	(2,546)	(2,298)	(2,148)	(2,125)	(2,125)
Total Operating Exp	(8,435)	(10,023)	(12,889)	(14,288)	(14,020)	(14,137)	(16,294)	(15,889)	(15,274)	(16,078)	(16,078)

Operating Income	3,241	1,745	3,011	3,594	4,653	5,468	8,701	8,681	6,916	7,228	7,228
% Revenue	15.9%	8.4%	11.0%	11.8%	14.6%	15.8%	20.2%	19.9%	17.2%	17.2%	17.2%

Interest Expense	(58)	(332)	(780)	(721)	(576)	(500)	(490)	(375)	(252)	(215)	(215)
Pre-tax Income	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664	7,013	7,013
Earnings of Discontinued Ops.	1,817	337	124	34	0	24	0	0	0	0	0
Provision for Taxes	(577)	(350)	(1,878)	(539)	(390)	(497)	(1,140)	(1,373)	(941)	6,389	6,389
Net Income to Company	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402	13,402
% Margin	21.7%	6.7%	1.7%	7.7%	11.6%	13.0%	16.4%	15.9%	14.3%	31.9%	31.9%

Minority Interest in Earnings	0	0	0	0	0	0	0	0	0	0	0
Net Income to Stockholders	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402	13,402

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	(1,837)	(344)	(133)	(49)	(21)	(46)	(29)	(28)	(22)	(51)	(51)

Net Income to Common	2,586	1,056	344	2,319	3,666	4,449	7,042	6,905	5,701	13,351	13,351
% Margin	12.7%	5.1%	1.3%	7.6%	11.5%	12.9%	16.3%	15.8%	14.2%	31.8%	31.8%

As Reported
Basic EPS (Continuing Ops)	1.73	0.71	0.20	1.32	2.07	2.51	3.97	3.94	3.28	7.67	7.67
Diluted EPS (Continuing Ops)	1.72	0.71	0.20	1.31	2.06	2.49	3.94	3.91	3.26	7.64	7.64

WA Basic Shares Out.	1,496.00	1,477.00	1,740.00	1,758.00	1,768.00	1,773.00	1,775.00	1,753.00	1,740.00	1,740.00	1,740.00
WA Diluted Shares Out.	1,506.00	1,483.00	1,749.00	1,770.00	1,781.00	1,786.00	1,789.00	1,764.00	1,749.00	1,748.00	1,748.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664	7,013	7,013
Addback: Net Interest Expense	58	332	780	721	576	500	490	375	252	215	215
Addback: Other Non Operating Expenses, Total	(88)	494	(79)	49	41	(21)	(6)	87	63	139	139
Addback: Depreciation & Amortization	1,427	1,351	3,019	3,278	3,014	3,327	3,538	3,267	3,243	3,218	3,218
Addback: Restructuring Charges	95	32	120	28	0	0	509	234	144	129	129
Addback: Merger / Acquisition Expenses	0	0	1,094	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	(207)	947	(45)	0	0	115	0	0	39	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	(1,163)	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	0	0	0	0	0	111	100	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	(100)	0	0	0	0	0
Addback: Other Unusual Items	(79)	0	0	167	63	0	0	0	(42)	0	0
Adjusted EBITDA	4,389	4,569	5,957	7,116	7,771	8,789	12,742	12,380	10,463	10,714	10,714
% Margin	21.5%	21.9%	21.7%	23.3%	24.4%	25.4%	29.6%	28.4%	26.1%	25.5%	25.5%

Adjusted EBIT	2,962	3,218	2,938	3,838	4,757	5,462	9,204	9,113	7,220	7,496	7,496
% Margin	14.5%	15.4%	10.7%	12.6%	14.9%	15.8%	21.4%	20.9%	18.0%	17.9%	17.9%

Adjusted Net Income Reconciliation
Net Income to Company	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402	13,402
Addback: Unusual Items	(191)	979	6	195	63	15	509	345	241	129	129
Less: Tax Benefit of Unusual Items (26%)	50	(255)	(2)	(51)	(16)	(4)	(132)	(90)	(63)	(34)	(34)
Adjusted Net Income	4,282	2,124	481	2,512	3,734	4,506	7,448	7,188	5,901	13,497	13,497
% Margin	21.0%	10.2%	1.8%	8.2%	11.7%	13.0%	17.3%	16.5%	14.7%	32.2%	32.2%

Errore di caricamento

Abbott Laboratories

BVL:ABT

Stati Uniti / Sanità / Attrezzature e rifornimenti sanitari

Cronol. dati finanziari 10 anni